Index

To M&A, or not to M&A?

Understanding (re)insurance portfolio valuation in real time

Review of 2023: Investor appetite returning

Annual returns of the ‘RISX’ equity index of listed companies with Lloyd’s businesses remained strong, and with lower correlation

RISX equity index surge over the last quarter benefits proven leaders

Successful leaders and smart follow-onlys likely to benefit at the expense of a middle market squeeze

Hedging tail risks through capital markets

Enhance solvency using swaps to take advantage immediately post-event

What is the value of Lloyd’s and how does it change daily?

Those two simple questions motivated our research into how capital markets data could be used to provide answers on Lloyd’s valuation and to measure its evolution over time. This culminated in the ICMR RISX index, launched in May 2021.

Specialty (re)insurance M&A - price to book multiple trends

RISX index suggests tidy return for Ascot’s investors

Positive earnings for 2021 priced-in despite major cat losses thus far

What do capital markets tell us about premium rate change for the global specialty (re)insurance industry?

RISX Index: more than just a benchmark

This article outlines some of the drivers behind the creation of the RISX index

Press release: ICMR launches RISX Index with Moorgate Benchmarks

ICMR launches innovative new ‘(re)insurance specialty equity index’ and selects Moorgate Benchmarks as its administrator

A new metric to assess the insurance cycle?

Research by ICMR shows that comparing stock performance of specialty re/insurance companies with the S&P 500 can provide new insight into the state of the insurance cycle

What does value creation mean in the Lloyd’s market?

Introducing the London Insurance Market Index